Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,502
Closed -$216K 155
2023
Q4
$216K Sell
7,502
-110
-1% -$3.33K 0.53% 130
2023
Q3
$252K Buy
7,612
+596
+8% +$21.1K 0.7% 69
2023
Q2
$257K Buy
7,016
+246
+4% +$9.57K 0.68% 83
2023
Q1
$276K Sell
6,770
-1,989
-23% -$85.9K 0.71% 77
2022
Q4
$449K Sell
8,759
-2,094
-19% -$100K 0.68% 30
2022
Q3
$475K Sell
10,853
-7,450
-41% -$362K 0.59% 56
2022
Q2
$960K Sell
18,303
-13,228
-42% -$674K 0.65% 13
2022
Q1
$1.63M Sell
31,531
-4,073
-11% -$211K 0.62% 16
2021
Q4
$2.1M Sell
35,604
-3,631
-9% -$180K 0.68% 2
2021
Q3
$1.69M Sell
39,235
-4,922
-11% -$218K 0.56% 30
2021
Q2
$1.73M Sell
44,157
-2,691
-6% -$105K 0.5% 78
2021
Q1
$1.7M Buy
46,848
+2,274
+5% +$80.7K 0.48% 109
2020
Q4
$1.64M Buy
44,574
+10,762
+32% +$395K 0.49% 94
2020
Q3
$1.18M Buy
33,812
+5,704
+20% +$200K 0.49% 79
2020
Q2
$872K Sell
28,108
-46,128
-62% -$1.57M 0.47% 95
2020
Q1
$2.3M Buy
74,236
+4,168
+6% +$142K 0.52% 70
2019
Q4
$2.6M Buy
70,068
+3,718
+6% +$132K 0.46% 119
2019
Q3
$2.26M Buy
66,350
+5,000
+8% +$182K 0.42% 124
2019
Q2
$2.52M Buy
61,350
+4,423
+8% +$176K 0.48% 89
2019
Q1
$2.29M Buy
56,927
+14,414
+34% +$577K 0.46% 89
2018
Q4
$1.76M Buy
42,513
+17,831
+72% +$740K 0.41% 37
2018
Q3
$1.03M Buy
24,682
+21,169
+603% +$815K 0.23% 60
2018
Q2
$121K Buy
+3,513
New +$120K 0.03% 102

Other funds holding PFE

Fort LP's PFE Position: Q1 2024 in Review

Fort LP sold out of Pfizer (PFE) in Q1 2024, closing a stake of 7,502 shares — an estimated $216K sold.

Fort LP first reported a position in PFE in Q2 2018 and held it in 23 quarters. The position peaked at $2.6M in Q4 2019. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Fort LP reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Fort LP sold 7,502 Pfizer shares in Q1 2024, an estimated $216K.
  • Fort LP first reported a position in Pfizer in Q2 2018 and held it in 23 quarters.
  • Fort LP's Pfizer position peaked at $2.6M in Q4 2019.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Fort LP's 13F filing for Q1 2024, filed 14 May 2024.